Trial Profile
Intermittent HEMOdialysis Anticoagulation With TINzaparin Versus Unfractionated Heparin: A Pilot Multicentre Randomized Controlled Trial (HEMO-TIN Trial)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tinzaparin sodium (Primary) ; Heparin
- Indications Embolism and thrombosis
- Focus Adverse reactions
- Acronyms HEMO-TIN
- 12 Oct 2016 Status changed from not yet recruiting to completed.
- 01 Sep 2013 New trial record